Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lindhout

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 1, 1992
Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasmaP Schoen, T Lindhout, H C Hemker
Thrombosis and Haemostasis|November 30, 1990
The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasmaT Lindhout, R Blezer, H C Hemker
Thrombosis and Haemostasis|December 22, 1988
The mode of action of heparin in plasmaS Béguin, T Lindhout, H C Hemker
Thrombosis and Haemostasis|February 28, 1989
The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparinS Béguin, T Lindhout, H C Hemker
Thrombosis Research|March 1, 1987
Neutralization of heparin by prothrombin activation productsJ Pieters, J Franssen, C Visch, et al.
Thrombosis Research|February 1, 1990
The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin IIIP Schoen, S Wielders, M Petitou, et al.
Biochemistry|June 5, 1984
Interaction of prothrombin with factor Va-phospholipid complexesP van de Waart, H C Hemker, T Lindhout
The Journal of Biological Chemistry|June 15, 1989
Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragmentsP Schoen, T Lindhout, G Willems, et al.
Haemostasis|January 1, 1986
Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin IIID Baruch, T Lindhout, R Wagenvoord, et al.
British Journal of Haematology|August 1, 1989
Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulantsM Galli, S Béguin, T Lindhout, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 1, 1992
Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasmaP Schoen, T Lindhout, H C Hemker
Thrombosis and Haemostasis|November 30, 1990
The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasmaT Lindhout, R Blezer, H C Hemker
Thrombosis and Haemostasis|December 22, 1988
The mode of action of heparin in plasmaS Béguin, T Lindhout, H C Hemker
Thrombosis and Haemostasis|February 28, 1989
The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparinS Béguin, T Lindhout, H C Hemker
Thrombosis Research|March 1, 1987
Neutralization of heparin by prothrombin activation productsJ Pieters, J Franssen, C Visch, et al.
Thrombosis Research|February 1, 1990
The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin IIIP Schoen, S Wielders, M Petitou, et al.
Biochemistry|June 5, 1984
Interaction of prothrombin with factor Va-phospholipid complexesP van de Waart, H C Hemker, T Lindhout
The Journal of Biological Chemistry|June 15, 1989
Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragmentsP Schoen, T Lindhout, G Willems, et al.
Haemostasis|January 1, 1986
Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin IIID Baruch, T Lindhout, R Wagenvoord, et al.
British Journal of Haematology|August 1, 1989
Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulantsM Galli, S Béguin, T Lindhout, et al.
Pageof 8